RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer

Clinical trial NCT05256745 · RECRUITING

Trial details

NCT number: NCT05256745
Sponsor: Georgetown University
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cancer Related Cognitive Decline Non-metastatic Breast Cancer

Start date: 2023-06-06
Primary completion: 2026-12-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.